Merin Kuruvilla
Novartis (United States)(US)
Publications by Year
Research Areas
Drug-Induced Adverse Reactions, Asthma and respiratory diseases, Urticaria and Related Conditions, Contact Dermatitis and Allergies, Dermatology and Skin Diseases
Most-Cited Works
- → Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease(2018)1,152 cited
- → International consensus statement on allergy and rhinology: Allergic rhinitis – 2023(2023)391 cited
- → Epidemiology and risk factors for asthma(2019)116 cited
- → Antibiotic Prophylaxis in Primary Immune Deficiency Disorders(2013)98 cited
- → Direct oral amoxicillin challenge without preliminary skin testing in adult patients with allergy and at low risk with reported penicillin allergy(2018)72 cited
- → Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement(2022)60 cited
- → Dupilumab treatment for allergic bronchopulmonary aspergillosis: A case series(2019)56 cited
- → Extrafollicular IgD+ B cells generate IgE antibody secreting cells in the nasal mucosa(2021)48 cited
- → Anaphylaxis to Drugs(2015)47 cited
- → Allergy Electronic Health Record Documentation: A 2022 Work Group Report of the AAAAI Adverse Reactions to Drugs, Biologicals, and Latex Committee(2022)43 cited